TF and neoplasm: At the end point, the average tumor volume in peptide-injected tumors was lower by about 75% and 85% for D-ΔN-Ter-Antp and Tf-D-LP4, respectively, relative to the PBS/DMSO-injected tumors (Figure 3C).